Tandem Diabetes Care (NSDQ:TNDM) has submitted a medical device license application to Health Canada in the hopes of launching its t:slim X2 insulin pump in Canada in the second half of this year. The San Diego, Calif.-based company expects that its device will be able to display both English and French and will include a 24-hour […]
Wall Street Beat
Senseonics’ implantable glucose monitor succeeds in 90-day trial
A 90-day trial involving patients with Type I and Type II diabetes showed that Senseonics‘ (NYSE:SENS) implantable continuous glucose monitor was safe and accurate compared to reference glucose values, according to a study published in Diabetes Technology & Therapeutics. The single-arm study enrolled 90 participants and implanted them with Senseonics’ Eversense device, which sends glucose data every […]
Mitralign raises $10m
Mitralign, which is looking to commercialize its namesake mitral valve treatment and pursue regulatory nods for its Trialign tricuspid valve device, said it raised nearly $10 million. The $9.8 million funding, of a hoped-for $30.2 million, came from 19 unnamed investors beginning last September, the Tewksbury, Mass.-based company said in a regulatory filing. Mitralign raised […]
Procept BioRobotics raises $118m for Aquablation prostate treatment
Procept BioRobotics said today that it raised $118 million in an equity round it plans to use on the commercialization of its Aquablation treatment for benign prostate hyperplasia. Redwood Shores, Calif.-based Procept said new backer Viking Global Investors led the round, joined by Perceptive Advisors and existing investors including CPMG. The Aquablation treatment combines Procept’s Aquabeam – […]
Baxter approves $1.5B addition to share repurchase plan
Baxter (NYSE:BAX) said today its board of directors approved a $1.5 billion addition to its existing share repurchasing plan. With the approval, the company’s share repurchasing plan has approximately $2.3 billion in repurchase authority, the Deerfield, Ill.-based company said. Shares can be repurchased through the open market or through private transactions at times and in amounts determined […]
Siemens plans EU-based IPO for Healthineers division
Siemens (NYSE:SI) subsidiary Healthineers yesterday announced plans for a German initial public offering it expects to complete during the first half of 2018. Parent company Siemens said the IPO will consist of a secondary offering of shares from existing holdings of Siemens and is planned to post on the Regulated Market of the Frankfurt Stock Exchange. Siemens […]
UPDATE: Robotics delay pushes Medtronic down despite fiscal Q3 beats
Medtronic (NYSE:MDT) shares took a hit today after the world’s largest medical device maker said its robot-assisted surgery platform has fallen behind schedule, despite fiscal third-quarter results that topped the consensus forecast on Wall Street. Fridley, Minn.-based Medtronic had predicted first-in-human cases during the fiscal year ending in April, with a full launch following in […]
Italian court convicts Boston Scientific employee in criminal case
A court in Italy levied more than $1 million in fines and penalties against Boston Scientific (NYSE:BSX) and other defendants after finding one of its employees guilty in a criminal case there, the company said today in a regulatory filing. The Court of Modena, Italy, ordered a trial back in February 2015 against Boston Scientific, a […]
Obalon: Whistleblower’s allegations ‘without merit’
Obalon Therapeutics (NSDQ:OBLN) said today that a probe by its audit committee found that the whistleblower allegations that last month sundered a $35 million offering are “without merit.” In January the San Diego-based company terminated the offering after the whistleblower told its independent auditors, KPMG, of the allegations of improper revenue recognition during the fourth quarter. […]
MiMedx shares tumble on internal accounting investigation, delayed 2017 earnings
MiMedx (NSDQ:MDXG) shares have lost nearly a third of their value today after the company announced it is delaying the release of its 2017 financial results due to an internal investigation into alleged issues with sales and distribution practices at the company. The Marietta, Ga.-based company said that its board’s audit committee has tapped a group of […]
Motus GI closes $18m IPO
Motus GI last week closed an initial public offering worth $18 million for its Pure-Vu system for intra-colonoscopy cleaning. Fort Lauderdale-based Motus said it plans to use the proceeds to commercialize Pure-Vu and for R&D, among other things. The company said it sold 3.5 million shares at $5 apiece, grossing $17.5 million, and also granted a 30-day […]